Tight controls and focus on innovation provide strong outlook for Roche
This article was originally published in Scrip
Taking Roche on the road to present its financial results is developing into a habit for CEO Severin Schwan, who brought his top team to London again on July 23rd to unveil another impressive performance from the world’s number five in pharma in ex-factory sales and clear number one in diagnostics.
You may also be interested in...
Johnson & Johnson's Ashley McEvoy explains how the global medtech business should change, seen through the lens of the coronavirus pandemic.
COVID-19 business volatility continues to impact the medtech industry, but Royal Philips is targeting modest comparable sales growth for 2020 after posting quarterly growth of 10%.
Germany’s COVID-19 testing strategy now permits the use and reimbursement of coronavirus antigen tests.